The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
Self-citationNewburger, J. W., Takahashi, M., Gerber, M. A., Gewitz, M. H., Tani, L. Y., Burns, J. C., Shulman, S. T., Bolger, A. F., Ferrieri, P., Baltimore, R. S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000145143.19711.78 · Cited by 1,937
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Self-citationHIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
Imbach, P., d'APUZZO, V., Hirt, A., Rossi, E., Vest, M., Barandun, S., Baumgartner, C., Morell, A., Schöni, M., & Wagner, H. P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92400-4 · Cited by 1,666
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,307
Weng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Shields, R. L., Namenuk, A. K., Hong, K., Meng, Y. G., Rae, J., Briggs, J., Xie, D., Lai, J., Stadlen, A., Li, B., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009483200 · Cited by 1,161
Fcγ Receptors: Old Friends and New Family Members
Nimmerjahn, F., & Ravetch, J. V. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.010 · Cited by 1,072
Self-citationAnti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,053
Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,037
Self-citationThe complement system in regulation of adaptive immunity
Carroll, M. C. (2004) · Nature Immunology · doi:10.1038/ni1113 · Cited by 1,035
Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin
Viard, I., Wehrli, P., Bullani, R., Schneider, P., Holler, N., Salomon, D., Hunziker, T., Saurat, J.-H., Tschopp, J., & French, L. E. (1998) · Science · doi:10.1126/science.282.5388.490 · Cited by 1,005
Musolino, A., Naldi, N., Bortesi, B., Pezzuolo, D., Capelletti, M., Missale, G., Laccabue, D., Zerbini, A., Camisa, R., Bisagni, G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8957 · Cited by 981
FcR γ chain deletion results in pleiotrophic effector cell defects
Takai, T., Li, M., Sylvestre, D., Clynes, R., & Ravetch, J. V. (1994) · Cell · doi:10.1016/0092-8674(94)90115-5 · Cited by 951
Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
(1999) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(99)80071-6 · Cited by 869
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc
Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N., Paulson, J. C., & Ravetch, J. V. (2008) · Science · doi:10.1126/science.1154315 · Cited by 849
Self-citationAugmented humoral and anaphylactic responses in FcγRII-deficient mice
Takai, T., Ono, M., Hikida, M., Ohmori, H., & Ravetch, J. V. (1996) · Nature · doi:10.1038/379346a0 · Cited by 826
Ferrara, C., Grau, S., Jäger, C., Sondermann, P., Brünker, P., Waldhauer, I., Hennig, M., Ruf, A., Rufer, A. C., Stihle, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108455108 · Cited by 770
Fehr, J., Hofmann, V., & Rappeler, U. (1982) · New England Journal of Medicine · doi:10.1056/nejm198205273062102 · Cited by 708
Arthritis Critically Dependent on Innate Immune System Players
Ji, H., Ohmura, K., Mahmood, U., Lee, D. M., Hofhuis, F. M. A., Boackle, S. A., Takahashi, K., Holers, V. M., Walport, M., Gerard, C., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00275-3 · Cited by 693
Junghans, R. P., & Anderson, C. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5512 · Cited by 684
T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura
Olsson, B., Andersson, P.-O., Jernås, M., Jacobsson, S., Carlsson, B., Carlsson, L. M. S., & Wadenvik, H. (2003) · Nature Medicine · doi:10.1038/nm921 · Cited by 669
FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity
Nimmerjahn, F., Bruhns, P., Horiuchi, K., & Ravetch, J. V. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.010 · Cited by 660
Self-citationUchida, J., Hamaguchi, Y., Oliver, J. A., Ravetch, J. V., Poe, J. C., Haas, K. M., & Tedder, T. F. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040119 · Cited by 642
Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway
Anthony, R. M., Kobayashi, T., Wermeling, F., & Ravetch, J. V. (2011) · Nature · doi:10.1038/nature10134 · Cited by 633
Roles of Fc receptors in autoimmunity
Takai, T. (2002) · Nature Reviews Immunology · doi:10.1038/nri856 · Cited by 626
Identification of a receptor required for the anti-inflammatory activity of IVIG
Anthony, R. M., Wermeling, F., Karlsson, M. C. I., & Ravetch, J. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810163105 · Cited by 547
Anti-Inflammatory Actions of Intravenous Immunoglobulin
Nimmerjahn, F., & Ravetch, J. V. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090232 · Cited by 525
Self-citationThe half-lives of serum immunoglobulins in adult mice
Vieira, P., & Rajewsky, K. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180221 · Cited by 445
Scallon, B. J., Tam, S. H., McCarthy, S. G., Cai, A. N., & Raju, T. S. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.09.005 · Cited by 396
Activation of natural regulatory T cells by IgG Fc–derived peptide “Tregitopes”
De Groot, A. S., Moise, L., McMurry, J. A., Wambre, E., Van Overtvelt, L., Moingeon, P., Scott, D. W., & Martin, W. (2008) · Blood · doi:10.1182/blood-2008-02-138073 · Cited by 392
DIVERGENT ROLES FOR F c RECEPTORS AND COMPLEMENT IN VIVO
Ravetch, J. V., & Clynes, R. A. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.421 · Cited by 366
Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor Antibody
Clarkson, S. B., Bussel, J. B., Kimberly, R. P., Valinsky, J. E., Nachman, R. L., & Unkeless, J. C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605083141907 · Cited by 365
Pillai, S., Netravali, I. A., Cariappa, A., & Mattoo, H. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075018 · Cited by 357
The Carbohydrate at FcγRIIIa Asn-162
Ferrara, C., Stuart, F., Sondermann, P., Brünker, P., & Umaña, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510171200 · Cited by 354
Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond
Hogarth, P. M., & Pietersz, G. A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd2909 · Cited by 348
Beers, S. A., French, R. R., Chan, H. T. C., Lim, S. H., Jarrett, T. C., Vidal, R. M., Wijayaweera, S. S., Dixon, S. V., Kim, H., Cox, K. L., et al. (2010) · Blood · doi:10.1182/blood-2010-01-263533 · Cited by 335
Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura
Debré, M., Griscelli, C., Bonnet, M.-C., Carosella, E., Philippe, N., Reinert, P., Vilmer, E., Kaplan, C., Fridman, W. H., & Teillaud, J.-L. (1993) · The Lancet · doi:10.1016/0140-6736(93)92000-j · Cited by 329
Fc Receptors Initiate the Arthus Reaction: Redefining the Inflammatory Cascade
Sylvestre, D. L., & Ravetch, J. V. (1994) · Science · doi:10.1126/science.8066448 · Cited by 321
Loss of function of a lupus-associated FcγRIIb polymorphism through exclusion from lipid rafts
Floto, R. A., Clatworthy, M. R., Heilbronn, K. R., Rosner, D. R., MacAry, P. A., Rankin, A., Lehner, P. J., Ouwehand, W. H., Allen, J. M., Watkins, N. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1288 · Cited by 316
Bruhns, P., Samuelsson, A., Pollard, J. W., & Ravetch, J. V. (2003) · Immunity · doi:10.1016/s1074-7613(03)00080-3 · Cited by 304
FcγRIIb controls bone marrow plasma cell persistence and apoptosis
Xiang, Z., Cutler, A. J., Brownlie, R. J., Fairfax, K., Lawlor, K. E., Severinson, E., Walker, E. U., Manz, R. A., Tarlinton, D. M., & Smith, K. G. C. (2007) · Nature Immunology · doi:10.1038/ni1440 · Cited by 296
Ephrem, A., Chamat, S., Miquel, C., Fisson, S., Mouthon, L., Caligiuri, G., Delignat, S., Elluru, S., Bayry, J., Lacroix-Desmazes, S., et al. (2008) · Blood · doi:10.1182/blood-2007-03-079947 · Cited by 292
Shushakova, N., Skokowa, J., Schulman, J., Baumann, U., Zwirner, J., Schmidt, R. E., & Gessner, J. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16577 · Cited by 284
The antiinflammatory activity of IgG: the intravenous IgG paradox
Nimmerjahn, F., & Ravetch, J. V. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061788 · Cited by 280
Self-citationPrasad, N. K. A., Papoff, G., Zeuner, A., Bonnin, E., Kazatchkine, M. D., Ruberti, G., & Kaveri, S. V. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3781 · Cited by 279
Primary immunodeficiency disorders: Antibody deficiency
Ballow, M. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.122466 · Cited by 277
van de Geijn, F. E., Wuhrer, M., Selman, M. H., Willemsen, S. P., de Man, Y. A., Deelder, A. M., Hazes, J. M., & Dolhain, R. J. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2892 · Cited by 274
Intravenous Immunoglobulin: An Update on the Clinical Use and Mechanisms of Action
NEGI, V.-S., ELLURU, S., SIBÉRIL, S., GRAFF-DUBOIS, S., MOUTHON, L., KAZATCHKINE, M. D., LACROIX-DESMAZES, S., BAYRY, J., & KAVERI, S. V. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9088-9 · Cited by 271
Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases
Li, N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24394 · Cited by 264
Podolanczuk, A., Lazarus, A. H., Crow, A. R., Grossbard, E., & Bussel, J. B. (2009) · Blood · doi:10.1182/blood-2008-07-166439 · Cited by 263
Restoration of Tolerance in Lupus by Targeted Inhibitory Receptor Expression
McGaha, T. L., Sorrentino, B., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1105160 · Cited by 261
Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity
Nimmerjahn, F., Anthony, R. M., & Ravetch, J. V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702936104 · Cited by 253
Self-citationBallow, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.030 · Cited by 253
Selective dysregulation of the FcγIIB receptor on memory B cells in SLE
Mackay, M., Stanevsky, A., Wang, T., Aranow, C., Li, M., Koenig, S., Ravetch, J. V., & Diamond, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051503 · Cited by 252
Cytotoxic antibodies trigger inflammation through Fc receptors
Clynes, R., & Ravetch, J. V. (1995) · Immunity · doi:10.1016/1074-7613(95)90155-8 · Cited by 250
Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells
Siragam, V., Crow, A. R., Brinc, D., Song, S., Freedman, J., & Lazarus, A. H. (2006) · Nature Medicine · doi:10.1038/nm1416 · Cited by 246
Kaneko, Y., Nimmerjahn, F., Madaio, M. P., & Ravetch, J. V. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051900 · Cited by 246
Self-citationMizushima, T., Yagi, H., Takemoto, E., Shibata‐Koyama, M., Isoda, Y., Iida, S., Masuda, K., Satoh, M., & Kato, K. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2011.01552.x · Cited by 245
Gonzalez, S. F., Lukacs-Kornek, V., Kuligowski, M. P., Pitcher, L. A., Degn, S. E., Kim, Y.-A., Cloninger, M. J., Martinez-Pomares, L., Gordon, S., Turley, S. J., et al. (2010) · Nature Immunology · doi:10.1038/ni.1856 · Cited by 243
Tackenberg, B., Jelčić, I., Baerenwaldt, A., Oertel, W. H., Sommer, N., Nimmerjahn, F., & Lünemann, J. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807319106 · Cited by 242
Self-citationHamaguchi, Y., Xiu, Y., Komura, K., Nimmerjahn, F., & Tedder, T. F. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052283 · Cited by 237
Self-citationKono, H., Kyogoku, C., Suzuki, T., Tsuchiya, N., Honda, H., Yamamoto, K., Tokunaga, K., & Honda, Z.-I. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi320 · Cited by 226
Inhibitory Pathways Triggered by ITIM-Containing Receptors
Bolland, S., & Ravetch, J. V. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60019-x · Cited by 220
Immunoglobulin G–mediated Inflammatory Responses Develop Normally in Complement-deficient Mice
Sylvestre, D., Clynes, R., Ma, M., Warren, H., Carroll, M. C., & Ravetch, J. V. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2385 · Cited by 202
FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo
Nimmerjahn, F., Lux, A., Albert, H., Woigk, M., Lehmann, C., Dudziak, D., Smith, P., & Ravetch, J. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014515107 · Cited by 200
Self-citation(2010) · Chapman & Hall/CRC Finance Series · doi:10.1201/b10338-4 · Cited by 199
Guidelines on the Use of Intravenous Immune Globulin for Hematologic Conditions
Anderson, D., Ali, K., Blanchette, V., Brouwers, M., Couban, S., Radmoor, P., Huebsch, L., Hume, H., McLeod, A., Meyer, R., et al. (2007) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2007.01.001 · Cited by 191
Fc receptors are major mediators of antibody based inflammation in autoimmunity
Hogarth, P. M. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00409-0 · Cited by 189
Willcocks, L. C., Carr, E. J., Niederer, H. A., Rayner, T. F., Williams, T. N., Yang, W., Scott, J. A. G., Urban, B. C., Peshu, N., Vyse, T. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915133107 · Cited by 189
Teeling, J. L., Jansen-Hendriks, T., Kuijpers, T. W., de Haas, M., van de Winkel, J. G. J., Hack, C. E., & Bleeker, W. K. (2001) · Blood · doi:10.1182/blood.v98.4.1095 · Cited by 183
Fossati-Jimack, L., Ioan-Facsinay, A., Reininger, L., Chicheportiche, Y., Watanabe, N., Saito, T., Hofhuis, F. M. A., Gessner, J. E., Schiller, C., Schmidt, R. E., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1293 · Cited by 180
Coelho, V., Krysov, S., Ghaemmaghami, A. M., Emara, M., Potter, K. N., Johnson, P., Packham, G., Martinez-Pomares, L., & Stevenson, F. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009388107 · Cited by 175
Hansen, R., & Balthasar, J. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613331 · Cited by 164
Distinct cell-specific control of autoimmunity and infection by FcγRIIb
Brownlie, R. J., Lawlor, K. E., Niederer, H. A., Cutler, A. J., Xiang, Z., Clatworthy, M. R., Floto, R. A., Greaves, D. R., Lyons, P. A., & Smith, K. G. C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072565 · Cited by 162
Nimmerjahn, F., & Ravetch, J. V. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_86 · Cited by 160
Self-citationPark-Min, K.-H., Serbina, N. V., Yang, W., Ma, X., Krystal, G., Neel, B. G., Nutt, S. L., Hu, X., & Ivashkiv, L. B. (2007) · Immunity · doi:10.1016/j.immuni.2006.11.010 · Cited by 158
IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes
Séïté, J.-F., Cornec, D., Renaudineau, Y., Youinou, P., Mageed, R. A., & Hillion, S. (2010) · Blood · doi:10.1182/blood-2009-12-261461 · Cited by 154
Monocyte Subsets Responsible for Immunoglobulin G-Dependent Effector Functions In Vivo
Biburger, M., Aschermann, S., Schwab, I., Lux, A., Albert, H., Danzer, H., Woigk, M., Dudziak, D., & Nimmerjahn, F. (2011) · Immunity · doi:10.1016/j.immuni.2011.11.009 · Cited by 152
Self-citationda Silveira, S. A., Kikuchi, S., Fossati‐Jimack, L., Moll, T., Saito, T., Verbeek, J. S., Botto, M., Walport, M. J., Carroll, M. C., & Izui, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012024 · Cited by 149
Intravenous immunoglobulin therapy in rheumatic diseases
Bayry, J., Negi, V. S., & Kaveri, S. V. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.61 · Cited by 145
Siglecs as positive and negative regulators of the immune system
Crocker, P. R., & Redelinghuys, P. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361467 · Cited by 141
von Gunten, S., Schaub, A., Vogel, M. T., Stadler, B. M., Miescher, S., & Simon, H. (2006) · Blood · doi:10.1182/blood-2006-05-021568 · Cited by 139
Banda, N. K., Hyatt, S., Antonioli, A. H., White, J. T., Glogowska, M. J., Takahashi, K., Merkel, T. J., Stahl, G. L., Mueller‐Ortiz, S. L., Wetsel, R. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102310 · Cited by 137
Regulation of B Cell Functions by the Sialic Acid-Binding Receptors Siglec-G and CD22
Jellusova, J., & Nitschke, L. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00096 · Cited by 128
Hartung, H.-P., Mouthon, L., Ahmed, R. A., Jordan, S. C., Laupland, K. B., & Jolles, S. R. A. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04024.x · Cited by 128
Käsermann, F., Boerema, D. J., Monika, R., Hofmann, A., Wymann, S., Zuercher, A. W., & Miescher, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037243 · Cited by 127
Hansen, R. J., & Balthasar, J. P. (2002) · Blood · doi:10.1182/blood.v100.6.2087 · Cited by 126
Vassilev, T. L., Gélin, C., Kaveri, S. V., Zilber, M., Boumsell, L., & Kazatchkine, M. D. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb03407.x · Cited by 120
Skokowa, J., Ali, S. R., Felda, O., Kumar, V. V., Konrad, S., Shushakova, N., Schmidt, R. E., Piekorz, R. P., Nürnberg, B., Spicher, K., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.3041 · Cited by 119
Crow, A. R., Song, S. M., Freedman, J. J., Helgason, C. D., Humphries, R. K., Siminovitch, K. A., & Lazarus, A. H. (2003) · Blood · doi:10.1182/blood-2003-01-0023 · Cited by 119
Leontyev, D., Katsman, Y., Ma, X., Miescher, S., Käsermann, F., & Branch, D. R. (2012) · Transfusion · doi:10.1111/j.1537-2995.2011.03517.x · Cited by 119
Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice
Kumar, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25536 · Cited by 118
Vassilev, T. L., Kazatchkine, M. D., Huyen, J. D. V., Mekrache, M., Bonnin, E., Mani, J. C., Lecroubier, C., Korinth, D., Baruch, D., Schriever, F., et al. (1999) · Blood · doi:10.1182/blood.v93.11.3624 · Cited by 116
A Codominant Role of FcγRI/III and C5aR in the Reverse Arthus Reaction
Baumann, U., Köhl, J., Tschernig, T., Schwerter-Strumpf, K., Verbeek, J. S., Schmidt, R. E., & Gessner, J. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.1065 · Cited by 116
Crow, A. R., Song, S. M., Semple, J. W., Freedman, J. J., & Lazarus, A. H. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03136.x · Cited by 115
IVI g‐mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR 1
Schwab, I., Biburger, M., Krönke, G., Schett, G. A., & Nimmerjahn, F. (2012) · European Journal of Immunology · doi:10.1002/eji.201142260 · Cited by 113
Self-citationGuhr, T., Bloem, J., Derksen, N. I. L., Wuhrer, M., Koenderman, A. H. L., Aalberse, R. C., & Rispens, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021246 · Cited by 113
Rudge, E. U., Cutler, A. J., Pritchard, N. R., & Smith, K. G. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011435 · Cited by 112
Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein.
Dubé, R., Rook, G. A. W., Steele, J. K., Brealey, R., Dwek, R. A., Rademacher, T. W., & Lennard‐Jones, J. E. (1990) · Gut · doi:10.1136/gut.31.4.431 · Cited by 111
Siragam, V., Brinc, D., Crow, A. R., Song, S. M., Freedman, J. J., & Lazarus, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22753 · Cited by 110
A close look at human IgG sialylation and subclass distribution after lectin fractionation
Stadlmann, J., Weber, A., Pabst, M., Anderle, H., Kunert, R., Ehrlich, H. J., Schwarz, H. P., & Altmann, F. (2009) · PROTEOMICS · doi:10.1002/pmic.200800931 · Cited by 109
Intravenous immunoglobulin preparations contain anti–Siglec-8 autoantibodies
von Gunten, S., Vogel, M. T., Schaub, A., Stadler, B. M., Miescher, S., Crocker, P. R., & Simon, H. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.01.023 · Cited by 107
Targeting Siglecs—A novel pharmacological strategy for immuno- and glycotherapy
Jandus, C., Simon, H., & von Gunten, S. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.018 · Cited by 103
Intravenous Immunoglobulin: Properties, Mode of Action and Practical Use in Dermatology
Prins, C., Gelfand, E. W., & French, L. E. (2007) · Acta Dermato Venereologica · doi:10.2340/00015555-0249 · Cited by 102
Differences between IGIV products: Impact on clinical outcome
Gelfand, E. W. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.11.003 · Cited by 101
Negative Signaling in Fc Receptor Complexes
Daëron, M., & Lesourne, R. (2006) · Advances in immunology · doi:10.1016/s0065-2776(05)89002-9 · Cited by 100
Sokos, D. R., Berger, M., & Lazarus, H. M. (2002) · Transplantation and Cellular Therapy · doi:10.1053/bbmt.2002.v8.pm11939601 · Cited by 100
von Gunten, S., Smith, D. F., Cummings, R. D., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.013 · Cited by 95
Weng, W., Negrin, R. S., Lavori, P. W., & Horning, S. J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0274 · Cited by 93
Crow, A. R., & Lazarus, A. H. (2008) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2007.12.001 · Cited by 88
A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?
Crow, A. R., Song, S. M., Semple, J. W., Freedman, J. J., & Lazarus, A. H. (2006) · Blood · doi:10.1182/blood-2006-05-023796 · Cited by 87
Altznauer, F., von Gunten, S., Späth, P., & Simon, H. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.09.045 · Cited by 85
Baudino, L., Nimmerjahn, F., da Silveira, S. A., Martínez-Soria, E., Saito, T., Carroll, M. C., Ravetch, J. V., Verbeek, J. S., & Izui, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1948 · Cited by 84
Self-citationOtten, M. A., van der Bij, G. J., Verbeek, S. J., Nimmerjahn, F., Ravetch, J. V., Beelen, R. H. J., van de Winkel, J. G. J., & van Egmond, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.6829 · Cited by 84
Self-citationCurrent therapy of the pemphigus group
Kasperkiewicz, M., Schmidt, E., & Zillikens, D. (2011) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2011.03.014 · Cited by 83
Low-affinity Fcγ receptors, autoimmunity and infection
Willcocks, L. C., Smith, K. G. C., & Clatworthy, M. R. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001161 · Cited by 81
Tsuboi, N., Ernandez, T., Li, X., Nishi, H., Culleré, X., Mekala, D. J., Hazen, M. M., Köhl, J., Lee, D. M., & Mayadas, T. N. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30141 · Cited by 78
Structural changes in the oligosaccharide chains of IgG in autoimmune MRL/Mp- lpr/lpr mice.
Mizuochi, T., Hamako, J., Nose, M., & Titani, K. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.6.1794 · Cited by 73
Analytical and Functional Aspects of Antibody Sialylation
Stadlmann, J., Pabst, M., & Altmann, F. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9409-2 · Cited by 71
Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo
Baerenwaldt, A., Lux, A., Danzer, H., Spriewald, B. M., Ullrich, E., Heidkamp, G. F., Dudziak, D., & Nimmerjahn, F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111810108 · Cited by 69
Self-citationSyed, S. N., Konrad, S., Wiege, K., Nieswandt, B., Nimmerjahn, F., Schmidt, R. E., & Gessner, J. E. (2009) · European Journal of Immunology · doi:10.1002/eji.200939884 · Cited by 67
Self-citationBond, A., Cooke, A., & Hay, F. C. (1990) · European Journal of Immunology · doi:10.1002/eji.1830201011 · Cited by 66
Intravenous Immunoglobulin and Cytokines
Pottier, L. L., Sapir, T., Bendaoud, B., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1423.044 · Cited by 62
Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice
Huang, H.-S., Sun, D., Lien, T.-S., & Chang, H. (2010) · Blood · doi:10.1182/blood-2010-03-275123 · Cited by 61
Soubrane, C., Tourani, J. M., Andrieu, J., Visonneau, S., Beldjord, K., Israël‐Biet, D., Mouawad, R., Bussel, J. B., Weil, M., & Khayat, D. (1993) · Blood · doi:10.1182/blood.v81.1.15.15 · Cited by 54
Jacobi, C., Claus, M., Wildemann, B., Wingert, S., Korporal, M., Römisch, J., Meuer, S. C., Watzl, C., & Giese, T. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.09.006 · Cited by 49
Protection and injury: the differing roles of complement in the development of glomerular injury
Sheerin, N., Springall, T., Abe, K., & Sacks, S. H. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1255::aid-immu1255>3.0.co;2-w · Cited by 47
Mechanisms of IVIG Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy
Tackenberg, B., Nimmerjahn, F., & Lünemann, J. D. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9398-1 · Cited by 47
Self-citationTreatment of immune thrombocytopenia with intravenous immunoglobulin and insights for other diseases
Imbach, P. A. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13593 · Cited by 47
Konrad, S., Ali, S. R., Wiege, K., Syed, S. N., Engling, L., Piekorz, R. P., Hirsch, E., Nürnberg, B., Schmidt, R. E., & Gessner, J. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804617200 · Cited by 44
Crow, A. R., Suppa, S. J., Chen, X., Mott, P. J., & Lazarus, A. H. (2011) · Blood · doi:10.1182/blood-2011-08-374223 · Cited by 44
Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes
Schaub, A., von Gunten, S., Vogel, M., Wymann, S., Rüegsegger, M., Stadler, B. M., Spycher, M. O., Simon, H., & Miescher, S. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02579.x · Cited by 42
Schwab, I., Seeling, M., Biburger, M., Aschermann, S., Nitschke, L., & Nimmerjahn, F. (2012) · European Journal of Immunology · doi:10.1002/eji.201242710 · Cited by 40
Self-citationIntravenous immunoglobulin up‐regulates the expression of the inhibitory FcγIIB receptor on B cells
Nikolova‐Ganeva, K., Tchorbanov, A. I., Djoumerska‐Alexieva, I., Nikolova, M. H., & Vassilev, T. L. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2009.36 · Cited by 36
Functional analysis of agalactosyl IgG in inflammatory bowel disease patients
Nakajima, S., Iijima, H., Shinzaki, S., Egawa, S., Inoue, T., Mukai, A., Hayashi, Y., Kondo, J., Akasaka, T., Nishida, T., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21459 · Cited by 34
FcγRIIB: a modulator of cell activation and humoral tolerance
Lehmann, B., Schwab, I., Böhm, S., Lux, A., Biburger, M., & Nimmerjahn, F. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.5 · Cited by 29
Self-citationAmelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?
Crow, A. R., Song, S. M., Suppa, S. J., Ma, S., Reilly, M. P., André, P., McKenzie, S. E., & Lazarus, A. H. (2010) · Blood · doi:10.1182/blood-2010-05-280115 · Cited by 23
Cited by
Immune-related adverse events of checkpoint inhibitors
Ramos-Casals, M., Brahmer, J. R., Callahan, M. K., Flores-Chávez, A., Keegan, N., Khamashta, M. A., Lambotte, O., Mariette, X., Prat, A., & Suárez-Almazor, M. E. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0160-6 · Cited by 1,412
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Tang, Y., Liu, J., Zhang, D., Xu, Z., Ji, J., & Wen, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01708 · Cited by 1,094
Dimitriadis, E., Menkhorst, E., Saito, S., Kutteh, W. H., & Brosens, J. J. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00228-z · Cited by 702
The function of Fcγ receptors in dendritic cells and macrophages
Guilliams, M., Bruhns, P., Saeys, Y., Hammad, H., & Lambrecht, B. N. (2014) · Nature Reviews Immunology · doi:10.1038/nri3582 · Cited by 639
Thompson, J. A., Schneider, B. J., Brahmer, J., Andrews, S., Armand, P., Bhatia, S., Budde, L. E., Costa, L., Davies, M., Dunnington, D., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0013 · Cited by 570
Metadata
- Authors
- Schwab, I., & Nimmerjahn, F.
- Venue
- Nature Reviews Immunology
- Published
- 2013-02-15
- Volume
- 13
- Issue
- 3
- Pages
- 176-189
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2094655231
- Cited by
- 820
- References
- 140
- FWCI
- 11.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.